Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Segesterone Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TherapeuticsMD Announces Second Quarter 2022 Financial Results
    TherapeuticsMD Announces Second Quarter 2022 Financial Results

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005058/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share
    POPSUGAR Launches New Women’s Health Destination, Collaboration TherapeuticsMD
    POPSUGAR Launches New Women’s Health Destination, Collaboration TherapeuticsMD

    26 Oct 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201026005705/en/POPSUGAR-Launches-New-Women%E2%80%99s-Health-Destination-%E2%80%9CFull-Disclosure%E2%80%9D-in-Collaboration-With-TherapeuticsMD

    BUSINESSWIRE
    26 Oct 2020
    Share Share
    TherapeuticsMD Provides Update on Third Quarter Progress
    TherapeuticsMD Provides Update on Third Quarter Progress

    25 Sep 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200925005296/en

    BUSINESSWIRE
    25 Sep 2020
    Share Share
    TherapeuticsMD Announces Patent Updates for ANNOVERA®
    TherapeuticsMD Announces Patent Updates for ANNOVERA®

    09 Sep 2020

    // BUSINESSNEWSWIRE

    https://www.businesswire.com/news/home/20200909005861/en/TherapeuticsMD-Announces-Patent-Updates-ANNOVERA%C2%AE

    BUSINESSNEWSWIRE
    09 Sep 2020
    Share Share
    TherapeuticsMD and Nurx Expand Access to ANNOVERA®
    TherapeuticsMD and Nurx Expand Access to ANNOVERA®

    15 Jul 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200715005282/en/TherapeuticsMD-Nurx-Expand-Access-ANNOVERA%C2%AE

    BUSINESSWIRE
    15 Jul 2020
    Share Share
    TherapeuticsMD Announces Issuance of First Orange Book Patent for ANNOVERA®
    TherapeuticsMD Announces Issuance of First Orange Book Patent for ANNOVERA®

    29 Apr 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200429005171/en/TherapeuticsMD-Announces-Issuance-Orange-Book-Listable-U.S.

    BUSINESSWIRE
    29 Apr 2020
    Share Share